![](https://d3ilqtpdwi981i.cloudfront.net/FrTvAuws5tL8uxBibnPmmZ442AI=/0x45:371x525/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/82/ad/f1/82adf153-54a3-4651-a204-272a3322674b/BHSF%20Pineapple%20Logo%20%28Imported%20Works%29.png)
Article
A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
All Publications
Publication Date
6-1-2021
Presented At:
2021 ASCO Annual Meeting
Content Type
Presentation
Publisher's Site:
View at Publisher Website
Citation Information
Yazmin Odia and Minesh Mehta. "A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma" (2021) Available at: http://works.bepress.com/minesh-mehta/496/